Immunocore
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
92 Park Drive Milton Park, Abingdon, Oxf...Phone Number
+441235438600Website
www.immunocore.comRevenue
$430.8 MillionStock Symbol
IMCRIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Immunocore
Founded in 2008, Immunocore Limited is a privately owned British clinical-stage biotechnology company. It develops biological drugs to treat cancer, infectious diseases, and autoimmune diseases using soluble T-cell receptor technology. They are headquartered in Milton, United Kingdom.Explore more
Immunocore Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunocore your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Immunocore had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Immunocore launches new products
Immunocore, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Immunocore is spiking on competitors!
Check if Immunocore has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Immunocore
Funding: Get notified immidiatlly once Immunocore has new funding data
Earning: See what the market has to say on Immunocore recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Immunocore as Masked Content
Find 3 more new buyers
Compare Similar Companies to Immunocore
Compare insights from companies similar to Immunocore, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Immunocore is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immunocore is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immunocore.
Immunocore financials insights
Gather financial insights about Immunocore, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$320M
2020
Series B
$130M
2021
Series C
$75M
Stock Offering
$297.1M
Immunocore Tech Stack
A closer look at the technologies used by Immunocore
See more technologies
Most Recent Scoops
Open Position
Person-Based
New Hire, Partnership
Open Position
Open Position
Open Position
Immunocore News & Media
Immunocore Q2 Earnings Call Highlights
Immunocore (NASDAQ:IMCR) reported continued growth for KIMMTRAK in the second quarter and first half of 2026, while advancing three late-stage melanoma trials and early-stage programs in oncology, HIV and Type 1 diabetes. The company recorded $223 million in KIMMTRAK net sales during the first halfImmunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...
Immunocore reports robust first-half revenue, advances multiple Phase 3 trials, and maintains a strong cash position despite expected headwinds.Immunocore reports second quarter financial results and provides a business update
Immunocore reports second quarter financial results and provides a business updateImmunocore to report second quarter 2026 financial results and host call on August 6, 2026
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
Read more news
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunocore
Sign Up For FreeTo access detailed company insights
Founded in 2008, Immunocore Limited is a privately owned British clinical-stage biotechnology company. It develops biological drugs to treat cancer, infectious diseases, and autoimmune diseases using soluble T-cell receptor technology. They are headquartered in Milton, United Kingdom.... Read More
